Ranked #1,719 of 8,699 institutional investors
Flagship Pioneering, LLC
Cambridge, MA
$1.64B
US stock portfolio at live prices · today +$8.1M (+0.50%)
Market closed. Prices as of Nov 20, 8:11 AM ET
- Value at quarter end (Q3 2026)
- $1.96B
- Change from Q2 2026
- +$415.5M (+26.98%)
- Positions
- 5 · 0 new, 0 sold out
- Filed
- Nov 16, 2026
Holdings
Q3 2026 13F, live pricesMRNA 56.3%GENB 39.6%SANA 2.65%FHTX 1.37%MCRB <0.1%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| MRNA Moderna, Inc. | 4,632,149 | $923M | 56.3% | Unchanged |
| GENB Generate Biomedicines, Inc. | 62,673,117 | $650M | 39.6% | Unchanged |
| SANA Sana Biotechnology, Inc. | 25,001,856 | $43.5M | 2.65% | Unchanged |
| FHTX Foghorn Therapeutics Inc. | 12,674,120 | $22.6M | 1.37% | Unchanged |
| MCRB Seres Therapeutics, Inc. | 1,155,850 | $1.5M | <0.1% | Unchanged |